相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cystic Fibrosis Therapeutics The Road Ahead
Lucas R. Hoffman et al.
CHEST (2013)
Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2
Vera Ivanova et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
Ian A. Pringle et al.
BIOMATERIALS (2012)
State of progress in treating cystic fibrosis respiratory disease
Patrick A. Flume et al.
BMC MEDICINE (2012)
The challenges and promises of new therapies for cystic fibrosis
Gerald B. Pier
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung Disease
Mayumi Oakland et al.
MOLECULAR THERAPY (2012)
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung
G. McLachlan et al.
GENE THERAPY (2011)
Genetic therapies for cystic fibrosis lung disease
Patrick L. Sinn et al.
HUMAN MOLECULAR GENETICS (2011)
Gene and cell therapy for cystic fibrosis: From bench to bedside
Massimo Conese et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
Oleh Taratula et al.
JOURNAL OF DRUG TARGETING (2011)
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine
Jung Soo Suk et al.
NANOMEDICINE (2011)
Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients
Kaoru Hida et al.
PLOS ONE (2011)
Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium
Maria D. I. Manunta et al.
PLOS ONE (2011)
AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis
Jarrod S. Johnson et al.
PLOS PATHOGENS (2011)
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Respiratory Syncytial Virus Engineered To Express the Cystic Fibrosis Transmembrane Conductance Regulator Corrects the Bioelectric Phenotype of Human Cystic Fibrosis Airway Epithelium In Vitro
Anna R. Kwilas et al.
JOURNAL OF VIROLOGY (2010)
Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin
Malgorzata S. Cartiera et al.
MOLECULAR PHARMACEUTICS (2010)
Toward Gene Therapy for Cystic Fibrosis Using a Lentivirus Pseudotyped With Sendai Virus Envelopes
Katsuyuki Mitomo et al.
MOLECULAR THERAPY (2010)
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Frank J. Accurso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cystic fibrosis: Exploiting its genetic basis in the hunt for new therapies
James L. Kreindler
PHARMACOLOGY & THERAPEUTICS (2010)
Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance
Olga B. Garbuzenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
Neeraj Vij et al.
JOURNAL OF NANOBIOTECHNOLOGY (2010)
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Samuel K. Lai et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles
Jung Soo Suk et al.
BIOMATERIALS (2009)
Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects
L. A. Pringle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Functional Cystic Fibrosis Transmembrane Conductance Regulator Expression in Cystic Fibrosis Airway Epithelial Cells by AAV6.2-Mediated Segmental Trans-Splicing
Yuhu Song et al.
HUMAN GENE THERAPY (2009)
Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug
Olga B. Garbuzenko et al.
PHARMACEUTICAL RESEARCH (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
Liqun Zhang et al.
PLOS BIOLOGY (2009)
Ciliated epithelial cell lifespan in the mouse trachea and lung
Emma L. Rawlins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C. Hyde et al.
NATURE BIOTECHNOLOGY (2008)
Nanoparticles for drug delivery to the lungs
Jean C. Sung et al.
TRENDS IN BIOTECHNOLOGY (2007)
In vivo animal models for drug delivery across the lung mucosal
Sally-Ann Cryan et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis
Margarida D. Amaral et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The epithelium as a target for therapy in cystic fibrosis
William R. Thelin et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAVS-pseudotyped vector in primates
Anne C. Fischer et al.
MOLECULAR THERAPY (2007)
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Samuel K. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mucus structure and properties in cystic fibrosis
Bruce K. Rubin
PAEDIATRIC RESPIRATORY REVIEWS (2007)
Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells
R Loi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes
TT Jubeh et al.
PHARMACEUTICAL RESEARCH (2004)
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
MW Konstan et al.
HUMAN GENE THERAPY (2004)
Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport
M Dawson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
S Ferrari et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
L Garcia-Contreras et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents
AJ Hirsh
ADVANCED DRUG DELIVERY REVIEWS (2002)
Pharmacological approaches to discovery and development of new mucolytic agents
M King et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Lung edema clearance:: 20 years of progress -: Selected contribution:: Lung hypoxia:: Antioxidant and antiapoptotic effects of liposomal α-tocopherol
T Minko et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors
CL Halbert et al.
JOURNAL OF VIROLOGY (2001)
Drug transfer through mucus
K Khanvilkar et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Evidence for stem-cell niches in the tracheal epithelium
DW Borthwick et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Bioadhesion - New possibilities for drug administration?
J Woodley
CLINICAL PHARMACOKINETICS (2001)
Cystic fibrosis sputum - A barrier to the transport of nanospheres
NN Sanders et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer
J Zabner et al.
JOURNAL OF VIROLOGY (2000)
分享论文
